Related Experiment Video
Updated: Jan 15, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Circulating Cardiovascular Proteomic Associations With Genetics and Disease
Kathryn A McGurk1,2,3, Lara Curran1,2,4, Arunashis Sau1,5
1National Heart and Lung Institute, Imperial College London, United Kingdom (K.A.M., L.C., A.S., F.S.N., B.H., J.S.W.).
Angiotensin-converting enzyme 2 (ACE2) shows a protective effect against hypertension and type-2 diabetes. This finding suggests potential therapeutic benefits of ACE2 for cardiovascular disease prevention.
Area of Science:
- Proteomics and Cardiovascular Disease Biomarkers
- Systems Biology and Disease Mechanisms
Background:
- Circulating proteome analysis offers insights into disease biomarkers and severity.
- Understanding protein-disease relationships is crucial for identifying therapeutic targets.
Purpose of the Study:
- To investigate the interplay between cardiovascular disease (CVD) risk factors and protein measures.
- To explore potential causal links mediated by circulating proteins in CVD development.
Main Methods:
- Analysis of 9 plasma proteins (e.g., ACE2, BNP, NT-proBNP) in over 45,000 UK Biobank participants.
- Utilized phenome-wide and genome-wide association studies (GWAS).
- Employed two-sample Mendelian randomization for causal inference.
Main Results:
- Circulating protein levels varied significantly with demographic and lifestyle factors (age, sex, alcohol, smoking, medication).
- GWAS identified genetic variants (near GCKR, APOE, SERPINA1) influencing protein levels (BAG3, CDKN1A, NOTCH1).
- Angiotensin-converting enzyme 2 (ACE2) demonstrated a protective role against hypertension and type-2 diabetes.
Conclusions:
- ACE2 is causally protective for hypertension and diabetes, suggesting therapeutic potential.
- This study enhances understanding of circulating protein pathways in cardiovascular disease dynamics.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease I: Introduction
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

